Found: 3
Select item for more details and to access through your institution.
A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 3, p. 1, doi. 10.1093/ofid/ofab089
- By:
- Publication type:
- Article
2281. Ceftolozane–tazobactam (C/T) Treatment Outcomes in Immunocompromised (IC) Patients with Multidrug-Resistant (MDR) Pseudomonas aeruginosa (PA) Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S781, doi. 10.1093/ofid/ofz360.1959
- By:
- Publication type:
- Article
Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 378, doi. 10.1007/s10637-018-0666-x
- By:
- Publication type:
- Article